Earlier today the MAPRx Coalition submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the memorandum Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, published on February 15, 2024.
Earlier today the MAPRx Coalition released the Issue Brief: Minimizing Affordability Challenges and Beneficiary Confusion. Linked HERE.
Highlights of the Issue Brief:
- Key finalized provisions from Part 1 Guidance
- Key proposed provisions from Part 2 Guidance
- Key insights from coalition members and the focus...
MAPRx Releases 2024 Part D Open Enrollment Guide
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2023 – December 7, 2023 for coverage beginning January 1, 2024. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...
MAPRx Submits Comments to CMS on Monthly Payment Cap Implementation
Earlier today, the MAPRx Coalition submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the implementation of the Medicare Prescription Payment Plan program set to take effect for Contract Year (CY) 2025 per the Memorandum Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on...
MAPRx Submits Comments to CMS on Medicare Drug Price Negotiation Program
Earlier today, the MAPRx Coalition submitted to the Centers for Medicare & Medicaid Services (CMS) comments regarding the implementation of the Medicare Drug Price Negotiation Program (MDPNP) for initial price applicability year 2026.
The Coalition appreciates the opportunity to comment on how Medicare intends to negotiate with
pharmaceutical manufacturers for lower...
MAPRx Releases 2023 Part D Open Enrollment Guide
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2022 – December 7, 2022 for coverage beginning January 1, 2023. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...
New MAPRx Report Examines the Exclusion of Anti-Obesity Medications in Medicare Part D
A new report commissioned by the MAPRx Coalition examines the growing clinical evidence for coverage of anti-obesity medications (AOMs) approved by the Food and Drug Administration in Medicare Part D.
As the medical community’s understanding of disease states evolves, MAPRx is calling on the Part D program to evolve...
MAPRx Submits Letter to Senate Leaders on Inflation Reduction Act
Earlier today, the MAPRx Coalition and 35 member organizations submitted a letter to Senate leadership ahead of their continued consideration of the Inflation Reduction Act of 2022 via the Senate's reconciliation process.
While members of the Coalition have differing views on other components of the expansive package, the Coalition and...
MAPRx Releases 2022 Part D Open Enrollment Guide
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2021 – December 7, 2021 for coverage beginning January 1, 2022. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...
MAPRx Letter to Congressional Leaders Supports Out-of-Pocket Cap
Earlier today, 29 members of the MAPRx Coalition sent a letter to Congressional leaders urging them to establish an out-of-pocket (OOP) cap for Medicare Part D to limit the amount Medicare beneficiaries have to pay for covered prescription drugs.
The Coalition continues to believe that the lack of an...